Flavonoid constituents in the leaves of Myrica rubra sieb. et zucc. with anti-inflammatory activity

Cheng, H.Y., T.C. Lin, K. Ishimaru, C.M. Yang, K.C. Wang, and C.C. Lin. 2003. In vitro antiviral activity of prodelphinidin B-2 3,3′-Di-O-gallate from Myrica rubra. Planta Medica 69: 953–956.

Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860–867.

D’Acquisto, F., M.J. May, and S. Ghosh. 2002. Inhibition of nuclear factor kappa B (NF-κB): an emerging theme in anti-inflammatory therapies. Molecular Interventions 2: 22–35.

Dalgleish, A.G., and K.J. O’Byrne. 2002. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Advances in Cancer Research 84: 231–276.

Forstermann, U., H.H. Schmidt, J.S. Pollock, H. Sheng, J.A. Mitchell, T.D. Warner, M. Nakane, and F. Murad. 1991. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochemical Pharmacology 42: 1849–1857.

Hensley, K., K.A. Robinson, S.P. Gabbita, S. Salsman, and R.A. Floyd. 2000. Reactive oxygen species, cell signaling, and cell injury. Free Radical Biology and Medicine 28: 1456–1462.

Inoue, T., Y. Aral, and M. Nagai. 1984. Diarylheptanoids in the bark of Myrica rubra sieb. et zucc. Yakugaku Zasshi 104: 37–41.

Kim, Y.I., S.H. Lee, and T.S. Cho. 1996. Isolation of anticancer agents from the leaves of Platycarya strobilacea S. et Z. Korean Journal of Pharmacognosy 27: 238–245.

Kubes, P., and D.M. McCafferty. 2000. Nitric oxide and intestinal inflammation. American Journal of Medicine 109: 150–158.

Lee, T.H., F. Qiu, G.R. Waller, and C.H. Chou. 2000. Three new flavonol galloyl glycosides from leaves of Acacia confusa. Journal of Natural Products 63: 710–712.

Lu, Y., and L.M. Wahl. 2005. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-κB activity in lipopolysaccharide-activated human primary monocytes. The Journal of Immunology 175: 5423–5429.

Martínez-Cayuela, M. 1995. Oxygen free radicals and human disease. Biochimie 77: 147–161.

Masuda, T., T. Someya, and A. Fujimoto. 2010. Phenolic inhibitors of chemical and enzymatic oxidation in the leaves of Myrica rubra. Bioscience, Biotechnology, and Biochemistry 74: 212–215.

Matsuda, H., M. Higashino, W. Chen, H. Tosa, M. Iinuma, and M. Kubo. 1995. Studies of cuticle drugs from natural sources. III. Inhibitory effect of Myrica rubra on melanin biosynthesis. Biological &/and Pharmaceutical Bulletin 18: 1148–1150.

Matsuda, H., T. Morikawa, J. Tao, K. Ueda, and M. Yoshikawa. 2002. Bioactive constituents of Chinese natural medicines. VII.1 Inhibitors of degranulation in RBL-2H3 cells and absolute stereo structures of three new diarylheptanoid glycosides from the bark of Myrica rubra. Biological &/and Pharmaceutical Bulletin 50: 208–215.

Nonaka, G., M. Muta, and I. Nishioka. 1983. Myricatin, a galloyl flavanonol sulfate and prodelphinidin gallates from Myrica rubra. Phytochemistry 22: 237–241.

Peri, K.G., P. Hardy, D.Y. Li, D.R. Varma, and S. Chemtob. 1995. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. Journal of Biological Chemistry 270: 24615–24620.

Sakurai, N., Y. Yaguchi, and T. Inoue. 1986. Triterpenoids from Myrica rubra. Phytochemistry 26: 217–219.

Smith, W.L., and R. Langenbach. 2001. Why there are two cyclooxygenase isozymes. The Journal of Clinical Investigation 107: 1491–1495.

Surh, Y.J., and H.K. Na. 2008. NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes and Nutrition 2: 313–317.

Thun, M.J., S.J. Henley, and T. Gansler. 2004. Inflammation and cancer: an epidemiological perspective. Novartis Foundation Symposium 256: 6–21.

Wang, S.J., Y. Tong, S. Lu, R. Yang, X. Liao, Y.F. Xu, and X. Li. 2010. Anti-inflammatory activity of myricetin isolated from Myrica rubra sieb. et zucc. Leaves. Planta Medica 76: 1492–1496.